• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单磷酰脂质A通过鼻内免疫增强不可分型流感嗜血杆菌特异性黏膜和全身免疫反应。

Monophosphoryl lipid A enhances nontypeable Haemophilus influenzae-specific mucosal and systemic immune responses by intranasal immunization.

作者信息

Iwasaki Taro, Hirano Takashi, Kodama Satoru, Kadowaki Yoshinori, Moriyama Munehito, Kawano Toshiaki, Suzuki Masashi

机构信息

Department of Otolaryngology, Faculty of Medicine, Oita University, Oita 879-5503, Japan.

Department of Otolaryngology, Faculty of Medicine, Oita University, Oita 879-5503, Japan.

出版信息

Int J Pediatr Otorhinolaryngol. 2017 Jun;97:5-12. doi: 10.1016/j.ijporl.2017.03.018. Epub 2017 Mar 19.

DOI:10.1016/j.ijporl.2017.03.018
PMID:28483250
Abstract

OBJECTIVE

Acute otitis media (AOM) is one of the most common infectious diseases in children. Nontypeable Haemophilus influenzae (NTHi) is Gram-negative bacteria that are considered major pathogens of AOM and respiratory tract infections. In this study, we used monophosphoryl lipid A (MPL), a toll-like receptor (TLR) 4 agonist, as an adjuvant to induce mucosal immune responses against NTHi to enhance bacterial clearance from the nasopharynx.

METHODS

Mice were administered 10 μg outer membrane protein (OMP) from NTHi and 0, 10, or 20 μg MPL intranasally once a week for 3 weeks. Control mice were administered phosphate-buffered saline alone. After immunization, these mice were challenged with NTHi. At 6 and 12 h after bacterial challenge, the mice were killed and nasal washes and sera were collected. The numbers of NTHi- and OMP-specific antibodies were quantified by enzyme-linked immunosorbent assay.

RESULTS

The MPL 10 and 20 μg group produced a significant reduction in the number of bacteria recovered from the nasopharynx at 12 h after bacterial challenge compared to the control group. OMP-specific IgA titers were also augmented in the MPL groups compared to the control and OMP groups.

CONCLUSION

MPL is suitable for eliciting effective mucosal immune responses against NTHi in the nasopharynx. These results demonstrate the possibility of an adjuvant that involves stimulation of the innate immune system by TLR4 agonists such as MPL for mucosal vaccination.

摘要

目的

急性中耳炎(AOM)是儿童最常见的传染病之一。不可分型流感嗜血杆菌(NTHi)是革兰氏阴性菌,被认为是AOM和呼吸道感染的主要病原体。在本研究中,我们使用单磷酰脂质A(MPL),一种Toll样受体(TLR)4激动剂,作为佐剂来诱导针对NTHi的黏膜免疫反应,以增强从鼻咽部清除细菌的能力。

方法

给小鼠每周一次经鼻内给予10μg NTHi的外膜蛋白(OMP)以及0、10或20μg MPL,共3周。对照小鼠仅给予磷酸盐缓冲盐水。免疫后,用NTHi攻击这些小鼠。在细菌攻击后6小时和12小时,处死小鼠并收集鼻腔灌洗液和血清。通过酶联免疫吸附测定法定量NTHi特异性抗体和OMP特异性抗体的数量。

结果

与对照组相比,MPL 10μg组和20μg组在细菌攻击后12小时从鼻咽部回收的细菌数量显著减少。与对照组和OMP组相比,MPL组的OMP特异性IgA滴度也有所增加。

结论

MPL适用于在鼻咽部引发针对NTHi的有效黏膜免疫反应。这些结果证明了一种佐剂的可能性,该佐剂涉及通过TLR4激动剂如MPL刺激先天性免疫系统进行黏膜疫苗接种。

相似文献

1
Monophosphoryl lipid A enhances nontypeable Haemophilus influenzae-specific mucosal and systemic immune responses by intranasal immunization.单磷酰脂质A通过鼻内免疫增强不可分型流感嗜血杆菌特异性黏膜和全身免疫反应。
Int J Pediatr Otorhinolaryngol. 2017 Jun;97:5-12. doi: 10.1016/j.ijporl.2017.03.018. Epub 2017 Mar 19.
2
Monophosphoryl lipid A induced innate immune responses via TLR4 to enhance clearance of nontypeable Haemophilus influenzae and Moraxella catarrhalis from the nasopharynx in mice.单磷酰脂质A通过Toll样受体4(TLR4)诱导先天性免疫反应,以增强小鼠鼻咽部不可分型流感嗜血杆菌和卡他莫拉菌的清除。
FEMS Immunol Med Microbiol. 2011 Dec;63(3):407-17. doi: 10.1111/j.1574-695X.2011.00866.x. Epub 2011 Oct 5.
3
Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.用rLP4/rLP6/UspA2蛋白联合RC529水性制剂进行鼻内免疫后,不可分型流感嗜血杆菌鼻腔定植的减少。
Vaccine. 2004 Sep 3;22(25-26):3449-56. doi: 10.1016/j.vaccine.2004.02.027.
4
The role of Toll-like receptor 4 in eliciting acquired immune responses against nontypeable Haemophilus influenzae following intranasal immunization with outer membrane protein.在用外膜蛋白进行鼻内免疫后,Toll样受体4在引发针对不可分型流感嗜血杆菌的获得性免疫反应中的作用。
Int J Pediatr Otorhinolaryngol. 2009 Dec;73(12):1657-65. doi: 10.1016/j.ijporl.2009.08.015. Epub 2009 Sep 17.
5
Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media.鼻内免疫增强了不可分型流感嗜血杆菌的清除,并减少了中耳炎小鼠模型中肿瘤坏死因子α产生的刺激。
Infect Immun. 2001 May;69(5):2964-71. doi: 10.1128/IAI.69.5.2964-2971.2001.
6
A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.单次鼻腔给予 fms 样酪氨酸激酶受体 3 配体,而不是腹腔内应用,可增强鼻咽部非典型流感嗜血杆菌特异性的长期黏膜免疫应答。
Vaccine. 2010 Mar 16;28(13):2510-6. doi: 10.1016/j.vaccine.2010.01.043. Epub 2010 Jan 29.
7
A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.流感嗜血杆菌的重组P4蛋白在鼻内免疫后可诱导对小鼠鼻咽部定植具有生物活性的特异性免疫反应。
Vaccine. 2005 Jan 26;23(10):1294-300. doi: 10.1016/j.vaccine.2004.08.042.
8
Effects of intranasal immunization on protective immunity against otitis media.鼻内免疫对中耳炎保护性免疫的影响。
Int J Pediatr Otorhinolaryngol. 1999 Oct 5;49 Suppl 1:S227-9. doi: 10.1016/s0165-5876(99)00165-2.
9
Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx.用来自不可分型流感嗜血杆菌的基于脂寡糖的结合疫苗进行鼻内免疫可增强小鼠鼻咽部的细菌清除能力。
FEMS Immunol Med Microbiol. 2003 Jan 21;35(1):1-10. doi: 10.1111/j.1574-695X.2003.tb00642.x.
10
Intranasal immunization with recombinant outer membrane protein P6 induces specific immune responses against nontypeable Haemophilus influenzae.用重组外膜蛋白P6进行鼻内免疫可诱导针对不可分型流感嗜血杆菌的特异性免疫反应。
Int J Pediatr Otorhinolaryngol. 2002 Sep 2;65(2):109-16. doi: 10.1016/s0165-5876(02)00076-9.

引用本文的文献

1
Effect of Anti-Programmed Cell Death-1 Antibody on Middle Ear Mucosal Immune Response to Intranasal Administration of Outer Membrane Protein.抗程序性细胞死亡蛋白-1抗体对鼻内给予外膜蛋白后中耳黏膜免疫反应的影响
Vaccines (Basel). 2025 Mar 13;13(3):313. doi: 10.3390/vaccines13030313.
2
The Respiratory Commensal Bacterium as a Mucosal Adjuvant for Nasal Vaccines.呼吸道共生细菌作为鼻用疫苗的黏膜佐剂
Vaccines (Basel). 2023 Mar 8;11(3):611. doi: 10.3390/vaccines11030611.
3
Innate Immunity in the Middle Ear Mucosa.中耳黏膜的固有免疫。
Front Cell Infect Microbiol. 2021 Oct 29;11:764772. doi: 10.3389/fcimb.2021.764772. eCollection 2021.
4
Panel 8: Vaccines and immunology.板块8:疫苗与免疫学。
Int J Pediatr Otorhinolaryngol. 2020 Mar;130 Suppl 1(Suppl 1):109839. doi: 10.1016/j.ijporl.2019.109839. Epub 2019 Dec 18.